Company research
BIOLASE, INC
CIK 811240Updated Sep 24, 2026
Securities
Historical securities (1)
BIOL · NYSE_AMERICAN · equity · closed Oct 2, 2024Name history
BIOLASE TECHNOLOGY INC · through May 30, 2012
BIOL price & chart
Historical security
This listing closed Oct 2, 2024. Live provider charts are shown only for current listings.
In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2023 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 35,101,000Source | 38,186,000Source | 55,284,000Source | 41,025,000Source |
| Property, Plant and Equipment, NetUSD | 5,525,000Source | 4,278,000Source | 1,067,000Source | 782,000Source |
| GoodwillUSD | 2,926,000Source | 2,926,000Source | 2,926,000Source | 2,926,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 6,566,000Source | 4,181,000Source | 29,972,000Source | 17,564,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 5,483,000Source | 5,841,000Source | 4,238,000Source | 3,059,000Source |
| Inventory, NetUSD | 11,433,000Source | 15,884,000Source | 12,929,000Source | 11,157,000Source |
| Assets, CurrentUSD | 24,863,000Source | 28,959,000Source | 49,354,000Source | 35,110,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 1,381,000Source | 3,053,000Source | 2,012,000Source | 3,018,000Source |
| Operating Lease, Right-of-Use AssetUSD | 1,519,000Source | 1,768,000Source | 1,717,000Source | 1,976,000Source |
| Other Assets, NoncurrentUSD | 268,000Source | 255,000Source | 220,000Source | 231,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 33,145,000Source | 33,297,000Source | 30,076,000Source | 30,997,000Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | — | 0Source | 34,000Source | 118,000Source |
| Common Stock, Value, IssuedUSD | 3,000Source | 8,000Source | 154,000Source | 98,000Source |
| Retained Earnings (Accumulated Deficit)USD | -316,800,000Source | -296,168,000Source | -267,534,000Source | -251,376,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -553,000Source | -733,000Source | -623,000Source | -385,000Source |
| Stockholders' Equity Attributable to ParentUSD | -247,000Source | 4,889,000Source | 25,208,000Source | 10,028,000Source |
| Additional Paid in Capital, Common StockUSD | 317,103,000Source | 301,782,000Source | 293,177,000Source | 261,573,000Source |
| Liabilities and EquityUSD | 35,101,000Source | 38,186,000Source | 55,284,000Source | 41,025,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 19,663,000Source | 17,807,000Source | 13,844,000Source | 11,223,000Source |
| Operating Lease, Liability, CurrentUSD | 888,000Source | 638,000Source | 405,000Source | 305,000Source |
| Accounts Payable, CurrentUSD | 6,065,000Source | 5,786,000Source | 3,309,000Source | 2,651,000Source |
| Operating Lease, Liability, NoncurrentUSD | 772,000Source | 1,259,000Source | 1,449,000Source | 1,774,000Source |
| Other Liabilities, NoncurrentUSD | 79,000Source | 362,000Source | 330,000Source | 1,056,000Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 8,881,000Source | 9,210,000Source | 8,276,000Source | 6,667,000Source |
| Deferred Revenue, CurrentUSD | 2,452,000Source | 2,111,000Source | 2,259,000Source | 1,905,000Source |
| Deferred Revenue, NoncurrentUSD | 256,000Source | 418,000Source | 329,000Source | 374,000Source |
| Long-term Debt, Excluding Current MaturitiesUSD | — | — | 13,603,000Source | 16,186,000Source |
| Long-term Debt, Current MaturitiesUSD | 2,265,000Source | 700,000Source | 0Source | — |
| Long-term Debt, Excluding Current MaturitiesUSD | 11,782,000Source | 13,091,000Source | 13,603,000Source | 16,186,000Source |
cash flow · annual statements
| Line item | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | -20,632,000Source | -28,634,000Source | -16,158,000Source | -16,829,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 2,798,000Source | 497,000Source | 400,000Source | 499,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 1,232,000Source | 2,303,000Source | 1,662,000Source | 3,370,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | -201,000Source | 1,643,000Source | 978,000Source | -4,286,000Source |
| Increase (Decrease) in InventoriesUSD | -969,000Source | 5,754,000Source | 1,375,000Source | 871,000Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | 0Source | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -14,091,000Source | -26,761,000Source | -16,710,000Source | -12,795,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -1,129,000Source | -3,727,000Source | -707,000Source | -96,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 1,311,000Source | 3,727,000Source | 707,000Source | 96,000Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 17,434,000Source | 4,603,000Source | 29,954,000Source | 24,349,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 2,385,000Source | -25,994,000Source | 12,299,000Source | 11,775,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 6,566,000Source | 4,181,000Source | 30,175,000Source | 17,876,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 1,918,000Source | 1,519,000Source | 1,771,000Source | 1,881,000Source |
| Income Taxes Paid, NetUSD | 41,000Source | 59,000Source | 171,000Source | 22,000Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 1,232,000Source | 2,303,000Source | 1,662,000Source | 3,370,000Source |
| Amortization of Debt Issuance CostsUSD | 426,000Source | 1,196,000Source | 356,000Source | 331,000Source |
| Amortization of Intangible AssetsUSD | 0Source | 0Source | 0Source | 0Source |
| DepreciationUSD | 2,800,000Source | 500,000Source | 400,000Source | 500,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | -351,000Source | -438,000Source | 452,000Source | -21,000Source |
| Gain (Loss) on Disposition of Other AssetsUSD | 141,000Source | — | — | — |
| Gain (Loss) Related to Litigation SettlementUSD | — | — | -315,000Source | — |
| Gain (Loss) on Extinguishment of DebtUSD | 0Source | 0Source | 3,014,000Source | — |
| General and Administrative ExpenseUSD | 10,216,000Source | 12,309,000Source | 11,258,000Source | 9,772,000Source |
| GoodwillUSD | 2,926,000Source | 2,926,000Source | 2,926,000Source | 2,926,000Source |
| Goodwill and Intangible Asset ImpairmentUSD | — | 0Source | 0Source | 0Source |
| Goodwill, Impairment LossUSD | 0Source | 0Source | 0Source | — |
| Impairment of Intangible Assets (Excluding Goodwill)USD | — | — | — | 0Source |
| Income Tax Expense (Benefit)USD | 31,000Source | 109,000Source | 65,000Source | 128,000Source |
| Inventory Write-downUSD | 0Source | 1,312,000Source | -275,000Source | -591,000Source |
| Net Income (Loss) Attributable to ParentUSD | -20,632,000Source | -28,634,000Source | -16,158,000Source | -16,829,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -37,619,000Source | -28,851,000Source | -16,704,000Source | -34,207,000Source |
| Nonoperating Income (Expense)USD | -2,664,000Source | -3,187,000Source | -338,000Source | 1,835,000Source |
| Operating ExpensesUSD | 34,661,000Source | 41,249,000Source | 32,960,000Source | 24,709,000Source |
| Proceeds from Issuance of Common StockUSD | 9,553,000Source | 5,602,000Source | 13,300,000Source | — |
| Proceeds from Stock Options ExercisedUSD | — | 0Source | 132,000Source | — |
income statement · annual statements
| Line item | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Total RevenueUSD | 49,164,000Source | 48,462,000Source | 39,188,000Source | 22,780,000Source |
| Cost of Goods and Services Sold | — | — | — | — |
| Operating Income (Loss)USD | -17,937,000Source | -25,338,000Source | -16,431,000Source | -18,536,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -20,601,000Source | -28,525,000Source | -16,093,000Source | -16,701,000Source |
| Income Tax Expense (Benefit)USD | 31,000Source | 109,000Source | 65,000Source | 128,000Source |
| Net Income (Loss) Attributable to ParentUSD | -20,632,000Source | -28,634,000Source | -16,158,000Source | -16,829,000Source |
| Earnings Per Share, BasicUSD per share | -29.44Source | -4.16Source | — | -0.56Source |
| Earnings Per Share, DilutedUSD per share | -29.44Source | -4.16Source | — | -0.56Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 1,278,000Source | 6,930,000Source | — | 61,136,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 1,278,000Source | 6,930,000Source | — | 61,136,000Source |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 0Source | 0Source | 0Source | 0Source |
| Current Income Tax Expense (Benefit)USD | 30,000Source | 110,000Source | 64,000Source | 127,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | -351,000Source | -438,000Source | 452,000Source | -21,000Source |
| Gain (Loss) Related to Litigation SettlementUSD | — | — | -315,000Source | — |
| General and Administrative ExpenseUSD | 10,216,000Source | 12,309,000Source | 11,258,000Source | 9,772,000Source |
| Goodwill, Impairment LossUSD | 0Source | 0Source | 0Source | — |
| Gross ProfitUSD | 16,724,000Source | 15,911,000Source | 16,529,000Source | 6,173,000Source |
| Interest Income (Expense), Nonoperating, NetUSD | -2,361,000Source | -2,749,000Source | 2,224,000Source | -2,359,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -37,619,000Source | -28,851,000Source | -16,704,000Source | -34,207,000Source |
| Nonoperating Income (Expense)USD | -2,664,000Source | -3,187,000Source | -338,000Source | 1,835,000Source |
| Operating ExpensesUSD | 34,661,000Source | 41,249,000Source | 32,960,000Source | 24,709,000Source |
| Research and Development ExpenseUSD | 6,004,000Source | 7,265,000Source | 6,048,000Source | 3,695,000Source |
| Selling and Marketing ExpenseUSD | 18,441,000Source | 21,675,000Source | 15,339,000Source | 11,242,000Source |